AndreulaCFLucianiANM RecchiaCarellaA: P25 new dose of Gd-DTPA in MRI of multiple sclerosis. Neuroradiology, 34: 60, 1992.
2.
ArnoldDLMatthewsPM: Proton Magnetic Resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease. Magn Reson Med, 14: 154–159, 1990.
3.
BannaMEl-RamahiK: Neurologic involvement in Behnect disease: Imaging findings in 16 patients. Am J Radiol, 157: 867–872, 1991.
4.
BarkhofFHommesOR: Quantitative MRI changes in Gadolinium-DTPA enhancement after high- dose intravenous methylprednisolone in multiple sclerosis. Neurology, 41: 1219–1222, 1991.
5.
BarkhofFValkJ: Gadopentetate Dimeglumine enhancement of multiple sclerosis lesions on long TR spin echo images at 0.6 T. AJNR, 13: 1257–1259, 1992.
6.
BraininMNeuholdA: Changes within the ‘normal’ cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI. J Neurol Neurosurg Psychiat, 52: 1355–1359, 1989.
7.
DoranMBydderGM: Magnetic Resonance: Perfusion and diffusion imaging. Neuroradiology, 32: 392–398, 1990.
8.
DrayerBPBurgerPHurwitzB: Magnetic Resonance imaging in multiple sclerosis: Decreased signal in thalamus and putamen. Ann Neurol, 22: 546–550, 1987.
9.
EdwardsMKBonninJM: White matter diseases. In: AtlasSW: Magnetic Resonance Imaging of the brain and spine. Raven Press, New York1991: 499.
10.
EdwardsMKSmithRR: Clinical utility of inversion recovery in the diagnosis of multiple sclerosis (Abstract). AJNR, 10: 898, 1989.
11.
FazekasFOffenbacherH: Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology, 38: 1822–1825, 1988.
12.
GallucciMAmicarelliI: MR imaging of white matter lesions in uncomplicated chronic alcoholism. AJNR, 13 (3): 395–398, 1989.
13.
GallucciMBozzaoASplendianiA: La Risonanza Magnetica nella patologia della sostanza bianca e dei gangli della base. In: PassarielloR: Diagnostica con Risonanza Magnetica. Cromac, Roma1990.
14.
GayDEsiriM: Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study. Brain, 114: 557–572, 1991.
15.
Gean-MartonADVezinaLG: Abnormal corpus callosum: A sensitive and specific indicator of multiple sclerosis. Radiology, 180: 215–221, 1991.
16.
GeisJRHendrickRE: White matter lesions: Role of spin density in MR imaging. Radiology, 170: 863–868, 1989.
17.
GrossmanRIBraffmanBH: Multiple sclerosis: Serial study of Gadolinium-enhanced MR imaging. Radiology, 169: 117–122, 1988.
18.
HalperinJJLuftBJ: Lyme neuroborreliosis: Central nervous system manifestations. Neurology, 39 (6): 753–759, 1989.
19.
HawkinsCPMackenzieF: Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain, 114: 801–810, 1991.
20.
HonigLSSheremataWA: Magnetic Resonance imaging of spinal cord lesions in multiple sclerosis. J Neurol Neurosurg Psychiat, 52: 459–466, 1989.
21.
HorowitzALKaplanRD: The ovoid lesion: A new MR observation in patients with multiple sclerosis.
22.
JustMHigerHP: Magnetic Resonance imaging in infections of the brain: Findings in tuberculosis, stenosis, toxoplasmosis, subacute sclerosing panencephalitis and multiple sclerosis. Neurosurg Rev, 10: 185–190, 1987.
23.
KermodeAGThompsonAJ: Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: Pathogenetic and clinical implications. Brain, 113: 1477–1489, 1990.
24.
KermodeAGToftsPS: Heterogeneity of blood-brain barrier changes in multiple sclerosis: An MRI study with Gadolinium-DTPA enhancement. Neurology, 40: 229–235, 1990.
25.
KoopmansRALiDKB: Chronic progressive multiple sclerosis: Serial Magnetic Resonance brain imaging over six months. Ann Neurol, 26: 248–256, 1989.
26.
LammogliaFJShortSR: Multiple sclerosis presenting as an intramedullary cervical cord tumour. Kans Med, 90: 219–221, 1989.
27.
LarssonHBFrederiksenJ: Assessment od demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med, 11: 337–348, 1989.
28.
LarssonHBWStubgaardM: Quantitation of blood-brain barrier defect by Magnetic Resonance imaging and Gadolinium-DTPA in patients with multiple sclerosis and brain tumours. Mag Reson Med, 16: 117–131, 1990.
29.
MiglioriOBozzaoA: Focolai atipici di demielinizzazione in soggetto operato per ‘meningioma maligno’ e sottoposto a radioterapia: Valutazione seriata con RM. In: ScottiG: Neuroradiologia, 1992, Edizioni del Centauro, Udine1992 (Atti X Congresso Nazionale AIN).
30.
MiglioriOOrlandiB: Evoluzione spontanea delle lesioni acute nella sclerosi multipla: Correlazioni fisiopatologiche mediante RM. In: ScottiG: Neuroradiologia, 1992, Edizioni del Centauro, Udine1992 (Atti X Congresso Nazionale AIN).
31.
MillerDHBarkhofF: Magnetic Resonance imaging in monitoring the treatment of multiple sclerosis: Concerted action guidelines. J Neurol Neurosurg Psychiat, 54: 683–688, 1991.
32.
MillerDHOrmerodIE: The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann neurol, 26: 635–639, 1989.
33.
MillerDHRobbSA: Magnetic Resonance imaging of inflammatory and demyelinating white matter diseases of childhood. Dev Med Child Neurol, 32: 97–107, 1990.
34.
MillerDHRudgeP: Serial Gadolinium enhanced Magnetic Resonance imaging in multiple sclerosis. Brain, 111: 927–939, 1988.
35.
MillerGMBakerHLJr: Spinal cord sarcoidosis: A new finding at MR imaging with Gd- DTPA enhancement. Radiology, 173: 839–843, 1989.
36.
MillerGMBakerHLJr: Central pontine myelinosis and its imitators: MR findings. Radiology, 168: 795–802, 1988.
37.
NesbitGMForbesGS: Multiple sclerosis: Histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology, 180: 467–474, 1991.
38.
NewcombeJHawkinsCP: Histopathology of multiple sclerosis lesions detected by Magnetic Resonance imaging in unfixed postmortem central nervous system tissue. Brain, 114: 1013–1023, 1991.
39.
NilssonOLarssonEMHoltasS: Myelopathy patients studied with Magnetic Resonance for multiple sclerosis plaques. Acta Neurol Scand, 76: 272–277, 1987.
40.
OrlandiBMiglioriO: Alterazioni della barriera emato-encefalica nelle lesioni demielinizzanti acute: Studio seriato in doppio cieco (trattati vs placebo) sull'evoluzione della risposta al contributo RM. In: ScottiG: Neuroradiologia, 1992, Edizioni del Centauro, Udine1992 (Atti X Congresso Nazionale AIN).
41.
OrmerodIEBronsteinA: Magnetic Resonance imaging in clinically isolated lesions of the brainstem. J Neurol Neurosurg Psychiat, 49: 737–743, 1986.
42.
OrmerodIECMillerDH: The Role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain, 110: 1579–1616, 1987.
43.
PoserCMPatyDW: New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol, 13: 227–231, 1983.
44.
PrineasJW: The neuropathology of multiple sclerosis. Handbook of clinical neurology: Demyelinating diseases. Elsevier Science Publishers BV, vol 3 (47): 1985.
45.
QuintDJ: Multiple sclerosis and imaging of the corpus callosum. Radiology, 180: 15–17, 1991.
46.
ReeseLCarrTJ: Magnetic Resonance imaging for detecting lesions in multiple sclerosis: Comparison with computed tomography and clinical assessment. Can Med Assoc J, 135: 639–643, 1986.
47.
SavoiardoMD'IncertiL: Multiple sclerosis, dysmyelinating and degenerative diseases. Rivista di Neuroradiologia, 3: 101–108, 1990.
48.
SchumacherGABeebeGW: Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci, 122: 552–568, 1965.
49.
SchwankhausJDPatronasN: Computed tomography and Magnetic Resonance imaging in adult- onset leukodystrophy. Arch Neurol, 45: 1004–1008, 1988.
50.
SmithRREdwardsMK: Imaging of optic neuritis using STIR MR. (Abstract). AJNR, 10: 905, 1989.
51.
SwansonJW: Multiple sclerosis: Update in diagnosis and review of prognostic factors. Mayo Clinic Proc, 64: 577–586, 1989.
52.
SzeGKrolG: Intramedullary disease of the spine: Diagnosis using gadolinium DTP A- enhanced MR imaging. Am J Radiol, 151: 1193–1204, 1988.
53.
ThompsonAJKermodeAG: Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol, 29: 53–62, 1991.
54.
UhlenbrockDSeidelD: MR imaging in multiple sclerosis: Comparison with clinical, CSF, and visual evoked potential findings. AJNR, 9: 59–67, 1988.
55.
ValkJvan der KnaapMS: Multiple sclerosis, neuromyelitis optica, concentric sclerosis and Shilder's diffuse sclerosis. In: ValkJvan der KnaapMS: Magnetic Resonance of myelin, myelination, and mylin disorders. Springer Verlag, Heidelberg1989: 179–205.
56.
van de VyverFLTruyenL: Improved sensitivity of MRI in multiple sclerosis by use of extensive standardised procedures. MRI, 7: 241–249, 1989.
57.
WallaceCJSelandTPChenFong T: Multiple sclerosis: The impact of MR imaging. Am J Radiol, 158: 849–857, 1992.
58.
WilloughbyEWGrochowskiE: Serial Magnetic Resonance scanning in multiple sclerosis: A second prospective study in relapsing patients. Ann Neurol, 25: 43–49, 1989.
59.
WolinskyJSNarayamaPAFenstermacherMJ: Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology, 40: 1764–1769, 1990.
60.
YetkinFZHaughtonVM: Multiple sclerosis: Specificity of MR for diagnosis. Radiology, 178: 447–451, 1991.
61.
YoungIRHallAS: Nuclear Magnetic Resonance imaging of the brain in multiple sclerosis. Lancet, II: 1063–1066, 1981.
62.
ZimmermannRDFlemingCA: Periventricular hyperintensity as seen by Magnetic Resonance: Prevalence and significance. Am J Radiol, 146: 443–450, 1986.